APDN - Applied DNA Company Long-Term Debts

Graphic logo of Applied DNA Sciences Inc (APDN)

Applied DNA Sciences (APDN) possesses significant pricing power in the data protection sector thanks to its unique LinearDNA platform. This price chart illustrating value trends reflects the dynamics of debt obligations, which currently stand at 0.00. Laboratory capacities for creating therapeutic molecules are being utilized with maximum efficiency. Additionally, the company is implementing robotic supply chain control, automating the process of applying and reading biomarks.

APDN: Applied DNA Corp Company Long-Term Debt 07/04/2022 - 10/07/2025

Applied DNA (APDN) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price adnas.com|APDN - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Applied DNA Sciences|APDN - Total Company Value
- book value of equity indicators:
Share Book Value Applied DNA Sciences|APDN - Company Book Value|Market Capitalization to Net Assets adnas.com|APDN - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Equity Applied DNA Sciences|APDN - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Applied DNA Corp|APDN - Company Aggregate Debts|Debts to Book Value Applied DNA Sciences|APDN - Company Long-Term Debts|Company Short-Term Indebtedness Applied DNA Sciences
Summary company analytics:Applied DNA Sciences
Manufactured products of Applied DNA Sciences

Long-term debt reflects the aggregate of obligations with a maturity exceeding one year. This metric measures a company's ability to attract low-cost capital for strategic development without the risk of an immediate loss of liquidity. By analyzing the size of the long-term debt, an investor assesses the sustainability of the financial leverage. Optimizing borrowings allows Applied DNA Sciences (APDN) to fund the development of LinearRx DNA-tagging systems, which is critical for maintaining strict biosafety standards and protecting unique patents.

Who Applied DNA Sciences competes with

Company Long-Term Debts Tempus Labs TEM|Qiagen - Company Long-Term Debts|IONS - Company Long-Term Debts|Repligen Corp. (RGEN) - Company Long-Term Debt|Long-Term Liabilities RNA (Avidity Corp)|Company Long-Term Debt CRISPR Therapeutics AG|genedx.com - Long-Term Liabilities|Company Long-Term Debt Ultragenyx (RARE)|Company Long-Term Debt BEAM (Beam Therapeutics Inc)|Company Long-Term Debts SRPT (Sarepta Therapeutics Inc)|Long-Term Debt Volume Twist Bioscience Corp (TWST)|10x Genomics, Inc. - Company Long-Term Debts|Long-Term Debt intelliatx.com|STOK: Company Long-Term Debts|Company Long-Term Indebtedness BLFS|Company Long-Term Liabilities WVE|MAZE: Company Long-Term Loans and Borrowings|Company Long-Term Debts SION|primemedicine.com - Company Long-Term Indebtedness|Company Long-Term Debt Taysha Gene Therapies, Inc. TSHA|QURE: Company Long-Term Indebtedness|MeiraGTx PLC - Company Long-Term Debts|RGNX - Company Long-Term Debts|SLDB (Solid Biosciences Inc.) - Company Long-Term Liabilities|ocugen.com - Company Long-Term Loans and Borrowings|Company Long-Term Debt PacBio|Benitec Biopharma Inc (BNTC) - Long-Term Debt Volume|Company Long-Term Debts DSGN|Company Long-Term Liabilities Rocket Corp RCKT|Company Long-Term Debts FDMT (4D Molecular Therapeutics)|Long-Term Debt Volume Lexeo Therapeutics Inc. (LXEO)|Korro Bio, Inc - Company Long-Term Debts|Long-Term Debt Editas Medicine Inc|Silence Therapeutics Inc. (SLN) - Company Long-Term Debt|Company Long-Term Indebtedness PRQR|CDXS (Codexis Inc) - Company Long-Term Debts|Company Long-Term Liabilities sangamo.com (SGMO)|Company Long-Term Debts NAUT|MGX - Long-Term Debt|Company Long-Term Debt Precision BioSciences DTIL|Long-Term Debt Volume Generation Bio Co (GBIO)|Boundless Bio, Inc. - Company Long-Term Debts|XCUR - Company Long-Term Debts|imunon.com (IMNN) - Company Long-Term Debt|Long-Term Liabilities PHIO (Phio Pharmaceuticals Corp.)|MBIO (Mustang Bio Inc) - Company Long-Term Debts|Company Long-Term Indebtedness RNAZ (TransCode)|Company Long-Term Debt Bionano Genomics, Inc. (BNGO)|bluebirdbio.com - Company Long-Term Indebtedness|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|OMGA: Company Long-Term Indebtedness|OMIC - Company Long-Term Debt|RGLS (Regulus) - Company Long-Term Indebtedness|SYRS: Company Long-Term Debts|telesisbio.com (TBIO) - Company Long-Term Debts|TCON (TRACON Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Debts Unity Biotechnology Inc.